- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 09.07. | Merck boosts respiratory portfolio with $10B acquisition of Verona Pharma and potential COPD blockbuster Ohtuvayre | ||
| 09.07. | Granules recalls 33K bottles of blood pressure med in US, citing failed stability tests | ||
| 09.07. | Trump renews 200% tariff threat on pharmaceuticals, indicates plan for grace period | ||
| 09.07. | Novo keeps China manufacturing investments rolling with $112M for new quality testing lab in Tianjin | ||
| 09.07. | Respiratory pharma royalty rally around rural COPD education and support drive | ||
| 08.07. | Biopharma layoffs for first half of the year jump 32% YOY | ||
| 08.07. | Advocacy groups, health networks and others back bill seeking to nix 'interchangeable' biosim tag | ||
| 08.07. | Southwest Airlines sues dozens of generic drugmakers for alleged price-fixing scheme | ||
| 08.07. | UCB extends Bimzelx ad campaign in wake of hidradenitis suppurativa approval | ||
| 08.07. | Novartis' malaria drug for babies wins world-first approval | ||
| 08.07. | Achieve sparks up Omnicom pact, securing agency support for nicotine dependence drug launch | ||
| 07.07. | Novo's Wegovy retakes top TV spending spot in June, edging out AbbVie, J&J immunology ads | ||
| 07.07. | HIV drugmaker Theratechnologies agrees to $254M buyout by CDMO Future Pak | ||
| 07.07. | Dizal to challenge J&J with FDA approval for lung cancer drug Zegfrovy | ||
| 07.07. | Amid $15B AstraZeneca partnership rumor, Summit needs $7.7B upfront to excite investors: analyst | ||
| 07.07. | KalVista bounces back from FDA delay with approval for oral rare disease med Ekterly | ||
| 07.07. | CDMO BioSpring beefs up nucleic acid production with new API plant | ||
| 02.07. | 53 biotech leaders urge FDA not to restrict mifepristone access over 'fatally flawed' report | ||
| 02.07. | Peter Pitts talks FDA outlook and industry's role | ||
| 02.07. | China approves 4 new drugs, including a global first-in-class medicine | ||
| 02.07. | AstraZeneca's Soriot is considering move of stock listing to the US: Times | ||
| 02.07. | Regulatory tracker: Merck nabs FDA priority review in bid to soup up Winrevair's label | ||
| 02.07. | Boehringer backs education drive to improve bronchiectasis management | ||
| 02.07. | Why 'emboldened' activist investors are taking the fight to biotechs | ||
| 02.07. | Regulatory tracker: Sobi's Gamifant gains new FDA approval in Still's disease |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .